Title : Tadalafil for the treatment of pulmonary arterial hypertension.

Pub. Date : 2011 Jun

PMID : 21702653






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tadalafil is a selective inhibitor of phosphodiesterase type-5 (PDE-5) that was originally developed for the treatment of male erectile dysfunction and recently approved for the treatment of pulmonary arterial hypertension (PAH). Tadalafil phosphodiesterase 5A Homo sapiens
2 Tadalafil is a selective inhibitor of phosphodiesterase type-5 (PDE-5) that was originally developed for the treatment of male erectile dysfunction and recently approved for the treatment of pulmonary arterial hypertension (PAH). Tadalafil phosphodiesterase 5A Homo sapiens